RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
|
|
|
-
epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
Authors: Sean A Hudson, Heath Ecroyd, Francis C Dehle, Ian F Musgrave, John A Carver
Journal of molecular biology 2009 Sep 25 -
Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells.
Authors: Salma Hazgui, Arnaud Bonnomet, Béatrice Nawrocki-Raby, Magali Milliot, Christine Terryn, Jérôme Cutrona, Myriam Polette, Philippe Birembaut, Jean-Marie Zahm
Respiratory research 2008
Thought leaders and organizations working on research involving egcg.
- Charite University, Berlin, Germany
- Louisiana State University - Shreveport
- National Center for Complementary and Alternative Medicine (NCCAM)
- Mayo Clinic
- Northumbria University
- Boston University School of Medicine
- University of Wisconsin
- University of Adelaide
- University of Tennessee
- National Taiwan University
-
Effects of Epigallocatechin Gallate (EGCG) in Healthy, Young Adults
conditions: Cognitive Function ; Mood
interventions: EGCG
-
Effect of EGCG on the Body's Response to Insulin
conditions: Hypertension ; Obesity ; Type 2 Diabetes ; Insulin Resistance
interventions: Epigallocatechin Gallate (EGCG)
-
EGCg in green tea inhibits flu infection
News-Medical. - December 24, 2009 -
Epigallocatechin Gallate (EGCg) in Green Tea Confirmed to Prevent Infection by New Type of H1N1 Flu Virus in Vitro
PR Newswire. - December 24, 2009
